ERA4Health Phase 2

ERA4Health Partnership Phase 2 is aimed to integrate new additional activities to the current ERA4Health Partnership. The main ambition of the partnership it is the contribution to the goal of Europe to be at the forefront of science and innovation in Health Research by 2050 and enhancing the biomedical research to provide a better health for citizens, not only in Europe but at international level. To be able to achieve this aim, ERA4Health Phase 2 will pursue the following specific objectives: SO1. Support relevant medical research including clinical fields and intervention areas (prevention, diagnosis, treatment) SO2. Improve the utilisation of existing health technologies in clinical practice SO3. Build capacity, in particular in conducting IICSs at European scale SO4. Implement and advance the practice of RRI across the breadth of the programme This Phase 2 of the Partnership will continue supporting relevant medical research and new knowledge generation in the research priority areas stablished in the ERA4Health long-term Strategic Research and Innovation Agenda (SRIA), with a particular focus devoted to support and fund multi-country Investigator-Initiated Clinical Studies (IICS). The research priority areas included in the SRIA are: nutrition and life-style related diseases, prevention and public health strategies, cardiovascular diseases, nano and advanced technologies for disease prevention, diagnostic and therapy. ERA4Health will fund non-commercial multi-country IICS to enhance this impactful and added value clinical research. The additional activities in ERA4Health Phase 2 will serve to provide support and building capacity in conducting multi-country IICSs and to overcome the identified challenges and obstacles in these type of IICSs.